Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764842 · ClinicalTrials.gov registry record
Efficacy of the CLP® Hip - Retrospective
A clinical trial, sponsored by Encore Medical, L.P..
- Terminated
- Registry status
- 61
- Enrollment target
NCT00764842: Clinical Trial study, sponsored by Encore Medical, L.P..
NCT00764842 is a clinical trial that was terminated before completion, run by Encore Medical, L.P.. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764842 was terminated before completion, sponsored by Encore Medical, L.P..
- TERMINATED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.
Interventions
- DEVICE Encore CLP® Hip stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-02 |
Why NCT00764842 stopped before completion
NCT00764842 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Encore CLP® Hip stem is the first listed.
NCT00764842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00764842 about?
NCT00764842 is a clinical study titled "Efficacy of the CLP® Hip - Retrospective". The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.
What is the current status of trial NCT00764842?
This trial is currently terminated. The enrollment target is 61 participants. The study started on 2008-01. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00764842?
The interventions under investigation include: Encore CLP® Hip stem (DEVICE).
Who is sponsoring clinical trial NCT00764842?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia